Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 4/20 | 0.44 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.44 |
| ▸ | APOBEC3G | Q9HC16 | 2/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.38 |
| ▸ | HTR1A | P08908 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | CETP | P11597 | 2/20 | 0.33 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | DHFR | P00374 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6684451 | 0.86 | GABRA1 (0.44) | GABRA1GABRB2TAAR1HTR1AKCNH2 | |
| Phosphine SCHEMBL11706517 | 0.84 | GABRA1 (0.43) | GABRA1GABRB2TAAR1HTR1AKCNH2 | |
| SCHEMBL8372953 | 0.83 | GABRA1 (0.41) | GABRA1GABRB2APOBEC3GTAAR1HTR1A | |
| SCHEMBL245773 | 0.80 | GABRA1 (0.57) | GABRA1GABRB2TAAR1HTR1AKCNH2 | |
| SCHEMBL30035899 | 0.78 | APOBEC3G (0.58) | GABRA1GABRB2APOBEC3GACHECETP | |
| SCHEMBL775852 | 0.78 | APOBEC3G (0.58) | GABRA1GABRB2APOBEC3GACHECETP | |
| Methane SCHEMBL28776675 | 0.78 | GABRA1 (0.55) | GABRA1GABRB2TAAR1HTR1AKCNH2 | |
| SCHEMBL31498538 | 0.78 | GABRA1 (0.55) | GABRA1GABRB2TAAR1HTR1AKCNH2 | |
| Methylamine SCHEMBL27545014 | 0.78 | GABRA1 (0.55) | GABRA1GABRB2TAAR1HTR1AKCNH2 | |
| Ammonia Solution, Strong SCHEMBL27320869 | 0.78 | GABRA1 (0.55) | GABRA1GABRB2TAAR1HTR1AKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8987516-B2 | Process for producing arylsulfur pentafluorides | UBE INDUSTRIES, LTD. (JP) | 2015-03-24 | — | — | US | disclosed |
| EP-2468722-B1 | Process for producing arylsulfur halotetrafluorides | UBE INDUSTRIES (JP) | 2014-10-01 | — | — | EP | disclosed |
| EP-2468721-B1 | Process for producing arylsulfur pentafluorides | UBE INDUSTRIES (JP) | 2014-02-26 | — | — | EP | disclosed |
| EP-2468720-B1 | Process for producing arylsulfur pentafluorides | UBE INDUSTRIES (JP) | 2013-11-27 | — | — | EP | disclosed |
| EP-2468719-B1 | Process for producing arylsulfur pentafluorides | UBE INDUSTRIES (JP) | 2013-10-16 | — | — | EP | disclosed |
| EP-2137144-B1 | PROCESS FOR PRODUCING ARYLSULFUR PENTAFLUORIDES | UBE INDUSTRIES (JP) | 2013-07-31 | — | — | EP | disclosed |
| US-8399720-B2 | Methods for producing fluorinated phenylsulfur pentafluorides | UBE INDUSTRIES, LTD. (JP) | 2013-03-19 | — | — | US | disclosed |
| EP-2468721-A1 | Process for producing arylsulfur pentafluorides | UBE Industries, Ltd. (JP) | 2012-06-27 | — | — | EP | disclosed |
| EP-2468719-A1 | Process for producing arylsulfur pentafluorides | UBE Industries, Ltd. (JP) | 2012-06-27 | — | — | EP | disclosed |
| EP-2468722-A1 | Process for producing arylsulfur halotetrafluorides | UBE Industries, Ltd. (JP) | 2012-06-27 | — | — | EP | disclosed |
| US-20100029992-A1 | Process for Producing Arylsulfur Pentafluorides | IM&T RESEARCH, INC. (US) | 2010-02-04 | — | — | US | disclosed |
| WO-2010014665-A1 | METHODS FOR PRODUCING ARYLSULFUR PENTAFLUORIDES | IM&T RESEARCH, INC. (US) | 2010-02-04 | — | — | WO | disclosed |
| EP-2137144-A1 | PROCESS FOR PRODUCING ARYLSULFUR PENTAFLUORIDES | IM&T Research, Inc. (US) | 2009-12-30 | — | — | EP | disclosed |
| US-20090287024-A1 | Process for Producing Arylsulfur Pentafluorides | IM&T RESEARCH, INC. (US) | 2009-11-19 | — | — | US | disclosed |
| US-7592491-B2 | Process for producing arylsulfur pentafluorides | IM&T RESEARCH, INC. (US) | 2009-09-22 | — | — | US | disclosed |
| WO-2008118787-A1 | PROCESS FOR PRODUCING ARYLSULFUR PENTAFLUORIDES | IM & T RESEARCH, INC. (US) | 2008-10-02 | — | — | WO | disclosed |
| US-20080234520-A1 | PROCESS FOR PRODUCING ARYLSULFUR PENTAFLUORIDES | IM&T RESEARCH, INC. (US) | 2008-09-25 | — | — | US | disclosed |
| US-5912212-A | OIL WITH 3-METHYL-5-TERT-BUTYL-4-HYDROXYPHENYL FATTY ESTER, SULFUR AND PHOSPHORUS | NIPPON OIL CO., LTD. (JP) | 1999-06-15 | — | — | US | disclosed |
| EP-0896050-A1 | Lubricating oil composition comprising a specific base oil and an oxidation inhibitor | NIPPON OIL CO., LTD. (JP) | 1999-02-10 | — | — | EP | disclosed |
| EP-0781834-A2 | Lubricating oil composition | NIPPON OIL CO. LTD. (JP) | 1997-07-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090287024-A1 | Process for Producing Arylsulfur Pentafluorides | PFAS, MPST, ARSA | GABRA1 755/4885GABRB2 1556/4885APOBEC3G 1330/4885 |
| US-20080234520-A1 | PROCESS FOR PRODUCING ARYLSULFUR PENTAFLUORIDES | PFAS, MPST, ARSA | GABRA1 755/4885GABRB2 1556/4885APOBEC3G 1330/4885 |
| US-20100029992-A1 | Process for Producing Arylsulfur Pentafluorides | PFAS, MPST, ARSA | GABRA1 755/4885GABRB2 1556/4885APOBEC3G 1330/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.